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1. Introduction 
Air pollution is composed of a mixture of toxins, consisting of particles and gases emitted in 
large quantities from many different combustion sources, including cars and industries. A 
variety of anthropogenic and natural particle sources are present in ambient air. Throughout 
the past decade, the composition of air pollution has changed in developed countries from 
classical type 1 pollution, consisting of sulfur dioxide and large dust particles, to modern 
type II pollution, characterized by nitrogen oxides, organic compounds, ozone, and ultra-
fine particles (Schäfer & Ring, 1997). 
Particulate matter (PM) is the principal component of indoor and outdoor air pollution. PM 
is a complex, multi-pollutant mixture of solid and liquid particles suspended in gas 
(Ristovski et al., 2011). PM originates from a variety of manmade and natural sources. 
Natural sources include pollen, spores, bacteria, plant and animal debris, and suspended 
materials. Human-made sources include industrial emissions and combustion byproducts 
from incinerators, motor vehicles, and power plants. Indoor sources include cigarette 
smoking, cooking, wood and other materials burned in stoves and fireplaces, cleaning 
activities that resuspend dust particles, and the infiltration of outdoor particles into the 
indoor environment (2003, McCormack et al., 2008). 
Vehicle emissions are the predominant source of fine PM (2.5 PM with an aerodynamic 
diameter <2.5 m) in urban areas, where most people live globally (Ristovski et al., 2011). 
Airborne PM less than 10m in aerodynamic diameter (PM 10) is a complex mixture of 
materials with a carbonaceous core and associated materials such as organic compounds, 
acids, and fine metal particles (Pagan et al., 2003). 
The physical properties of PM including the mass, surface area, and number/size/ 
distribution of particles, as well as their physical state, influence respiratory health in 
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different ways (Ristovski et al., 2011). The primary exposure mechanism to PM and other 
particle sources is by inhalation (Ristovski et al., 2011). 
Growing epidemiologic evidence indicates that inhalation of airborne PM increases 
respiratory and cardiac mortality and morbidity, and produces a range of adverse 
respiratory health outcomes such as asthma, lung function decline, lung cancer, and chronic 
obstructive pulmonary disease (COPD) (Ayres et al., 2008, Ristovski et al., 2011). 
Epidemiologic data indicate that air pollution also aggravates asthma, with the exacerbation 
correlating with levels of environmental particles (Schwartz et al. 1993). Likewise, the rate of 
decline seen in COPD patients correlates with the level of air pollution where the patients 
live (Pope & Kanner, 1993).  
PM induces inflammation, innate and acquired immunity, and oxidative stress. It also 
increases innate and adaptive immune responses in both animals and humans. That derived 
from traffic and various industries is associated with allergic airway disorders, including 
asthma. Understanding the mechanisms of lung injury from PM will enhance efforts to 
protect at-risk individuals from the harmful respiratory effects of air pollutants. PM 
functions as an adjuvant inducing lung inflammation to allergens or respiratory viruses. 
Inhalation of PM aggravates respiratory symptoms in patients with chronic airway diseases, 
but the mechanisms underlying this response remain poorly understood. This review 
focuses on the adverse effects of exposure to ambient PM air pollution on the exacerbation, 
progression, and development of asthma, COPD, and respiratory diseases. It also attempts 
to offer insights into the mechanisms by which particles may influence airway 
inflammation, and several mechanisms that may explain the relationship between 
particulate air pollutants and respiratory diseases are discussed.  
2. Adverse effects of PM on respiratory diseases identified in 
epidemiologic studies (Figure 1) 
PM is a mixture of organic and inorganic solid and liquid particles of different origins, size, 
and composition. It is a major component of urban air pollution and greatly effects health. 
Penetration of the tracheobronchial tract is related to particle size and the efficiency of 
airway defense mechanisms (D'Amato et al., 2010). Particles smaller than 10 m can get into 
the large upper branches, just below the throat, where they are caught and removed (by 
coughing and spitting or swallowing). Particles smaller than 5 m can get into the bronchial 
tubes at the top of the lungs, while particles smaller than 2.5 m in diameter can penetrate 
the deepest (alveolar) portions of the lung. If these particles are soluble in water, they pass 
directly into the blood in the alveolar capillaries. If they are insoluble in water, they are 
retained deep within the lungs for extensive periods of time. About 60% of PM10 particles 
(by weight) have a diameter of 2.5 m or less.  
According to the World Health Organization, 24% of the global disease burden and 23% of 
all deaths are attributable to environmental factors (Pruss-Ustun & Corvalan, 2006). The 
cause of, and route of exposure that lead to, disease and death is often complex and poorly  
 




Figure 1. Particulate matter effect on respiratory diseases. 
understood. The increased air pollution emanating from traffic and various industries has 
caused an increase in the incidence of allergic diseases. In children, acute exposure to air 
pollution is associated with increased respiratory symptoms and decreased lung function. 
Chronic exposure to increased levels of inhalable particles is associated with up to a 
threefold increase in non-specific respiratory symptoms, such as chronic cough, asthma, and 
chronic airway diseases (Nicolai, 1989). Exposure to heavy traffic leads to significant 
increases in respiratory symptoms, while a direct effect of traffic on asthma initiation has 
been documented (Nicolai, 1989). Indeed, outdoor air pollution levels have been associated 
with adverse health in asthma subjects (Nicolai, 1989). Exposure to traffic-related air 
pollution, in particular diesel exhaust particles (DEP), may lead to reduced lung function in 
children living near major motorways (Brunekreef et al., 1997). The prevalence of airway 
hyper-responsiveness (AHR) has increased over the last few decades, potentially because of 
environmental factors. Air pollution is convincingly associated with many signs of asthma 
aggravation, including pulmonary function decrease, increased AHR, additional visits to 
emergency departments, increased hospital admissions, increased medication use, and more 
reported symptoms. It is also associated with inflammatory changes, interactions between 
air pollution and allergen challenges, and changes in immune response (Koenig, 1999). 
There is a significant association between traffic-related air pollution and wheezing in 
children (Hisch et al., 1999), and exposure to DEPs may reduce lung function in children 
living near motorways. DEPs account for most airborne PM in the world’s largest cities 
(Rield & Diaz-Sanchez, 2005), and are composed of fine (2.5–0.1m) and ultra-fine (<0.1m) 
particles, although primary DEPs can coalesce to form aggregates of varying sizes. Acute 
exposure to DEPs causes irritation of the nose and eyes, headache, lung function 
abnormalities, fatigue, and nausea, while chronic exposure is associated with cough, sputum 
production, and diminished lung function (McCreanor et al., 2007). 
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There is strong evidence that episodes of air pollution aggravate respiratory disease, 
especially asthma. A study of the relationship between fine PM and emergency room visits 
for asthma in the metropolitan Seattle area was designed to substantiate that air pollution 
was a risk factor for asthma (Mortimer et al., 2002). Using Poisson regression analyses that 
controlled for weather, season, time trends, age, hospital, and day of the week, a significant 
association was found between fine particles measured at the monitoring station and visits 
to emergency departments in eight nearby participating hospitals (Mortimer et al., 2002). 
There are relatively few studies on the correlation between indoor PM and asthma. A sub-
group of 10 children not using inhaled corticosteroids in Seattle were found to have 
decreased pulmonary function associated with indoor PM2.5 exposure (Koenig et al., 2005). 
Moreover, PM2.5 originating from indoor sources was more potent in decreasing lung 
function than was PM exposure outdoors (Koenig et al., 2005). A California study of 19 
predominantly white children found significant decreases in lung function (FEV1) 
associated with indoor PM. While this study found associations between ambient PM and 
lung function, a stronger association was found with indoor central site PM concentrations 
than outdoor PM (McConnellet et al., 2003). Significant determinants of indoor PM 
concentrations include smoking, sweeping, and stove use (McCormack et al., 2008), 
activities that are modifiable and provide opportunities for exposure reduction. Smoking 
has been a major source of indoor particulates over the last several decades, with more than 
30% of all U.S. children exposed to secondhand smoke (Winickoff et al., 2005). 
Asthma symptoms are associated with indoor coarse PM. For example, in a previous study, 
every 10 mg/m3 increase in indoor PM 2.5–10 concentration led to a 6% increase in the number 
of days of coughing, wheezing, or chest tightness, after adjusting for age, race, sex, 
socioeconomic status, season, indoor fine PM, and ambient fine and coarse PM concentrations 
(Breysse et al., 2010). This study also found that higher indoor coarse PM concentrations were 
also associated with increased incidences of symptoms severe enough to slow a child’s 
activity, cause wheezing that limited speaking ability, nocturnal symptoms, and rescue 
medication use; and although outdoor coarse PM was not associated with increased asthma 
symptoms or rescue medication use, fine PM was positively associated with respiratory 
symptoms and rescue medication use (Breysse et al., 2010). These findings demonstrate that 
both indoor coarse and fine PM distinctly affect respiratory health in children with asthma. 
Although fine PM may be capable of reaching the alveoli, the regions responsible for gas 
exchange, the deposition of coarse PM in upper airways and subsequent bronchial hyper-
reactivity may be responsible for the symptomatic response measured in preschool children 
(Breysse et al., 2010). 
In asthmatic children attending school in urban Amsterdam, black smoke was the most 
important air pollution indicator associated with acute changes in lung function, respiratory 
symptoms, and medication use (Gielen et al., 1997). In one polluted area (Jang et al., 2003), 
670 schoolchildren (100%) had normal pulmonary function, while 257 (38.3%) had AHR. A 
significantly greater proportion of children had AHR in the polluted area (45.0% [138/306], 
6.50±0.48) than in rural (31.9% [52/163], 9.84±0.83) or coastal (33.3% [67/201], 7.17±0.68) areas. 
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Schoolchildren with atopy had lower PC20 levels than those without (5.98± 0.60 vs. 
8.15±0.45, p < 0.001). In a multiple logistic regression model, a positive allergy skin test and 
living in the polluted area near a chemical factory were independently associated with AHR 
(odds ratio for location=2.4875, CI 1.6542-3.7406, P < 0.01; odds ratio for allergy skin 
test=1.5782, CI 1.1130 - 2.2379, p < 0.05), when adjusted for sex, parents' smoking habits, age, 
body mass index, nose symptoms, and lung symptoms. This suggests that air quality near 
the polluted area contributes to the development of AHR, and that controlling air pollution 
is important for preventing the development of asthma. Asthma, a complex disease 
influenced by both environmental and genetic factors, is common and the prevalence is 
increasing worldwide (Holgate, 1999). Indoor environmental factors thought to modify 
asthma severity include pollutants such as PM, nitrogen oxides, secondhand smoke, and 
allergens from pests, pets, and molds (Diette, 2008). In contrast to the outdoors, individuals 
have a greater ability to modify indoor environmental exposure risks, making indoor air 
pollution an attractive target for disease prevention (Breysse et al., 2010). 
DEP plays a role in increasing asthma prevalence, although a causal relationship has yet to 
be established. In a modification of the classical ovalbumin sensitization and challenge 
model, mice were exposed to intranasal DEP and challenged with aerosolized DEP on days 
6–8 (Song et al., 2008). Delivery of aerosolized DEP, following exposure with intranasal 
DEP, induced a significant increase in methacholine-induced airway hyper-responsiveness. 
Pope and Dockery (Pope & Dockery, 2006) suggested that there is a 0.6–2.2% increase in 
respiratory mortality risk for a 10 g/m3 increase in ambient PM. Indeed, many cohort 
studies have demonstrated that airborne PM, of which PM is a major contributor (Robinson 
et al., 2010), causes respiratory mortality and morbidity (Pope & Dockery, 2006).  
A cross-sectional study of 20,000 children between 6 and 12 years old found a weak association 
between decreased pediatric lung function and secondhand smoking (Moshammer et al., 
2006). Also, children living in homes that use organic fuels for cooking, heating, and lighting 
are exposed to much higher levels of PM than children living in homes where parents smoke 
and use clean fuels (e.g., a mean indoor level of 200 mg/m3 PM per 24 h; Jiang & Bell, 2008). 
There are many sources of air pollution in the home environment. Air pollution inside 
homes consists of a complex mixture of agents penetrating from ambient outdoor air, and 
agents generated by indoor sources. Indoor pollutants can vary in their potential health 
hazard and intensity, as well as in their distribution across geographic areas, cultural 
backgrounds, and socioeconomic status (Breysse et al., 2010). 
In a British cohort of 4,400 preschool children, a significant association was found between 
exposure to primary PM10 at the home address and prevalence of coughing without a cold 
(Pierse et al, 2006). Data from the Third U.S. National Health and Nutrition Examination Survey 
(1988–1994) found that exposure to environmental tobacco smoke is associated with increased 
prevalence of pediatric asthma, wheezing, and chronic bronchitis (Gergen et al., 1998). 
Entering adulthood with impaired lung function is a non-specific risk factor for respiratory 
disease in adulthood. Lower lung function predisposes children to further structural 
 
Air Pollution – A Comprehensive Perspective 
 
158 
damage to the developing lung (Grigg, 2009). COPD is the non-specific terminology 
commonly used to describe the spectrum of diseases limiting respiratory airflow, e.g., 
asthma, chronic bronchitis, and emphysema (Matthay, 1992). There are several reasons why 
environmental exposures in childhood are relevant to the pathogenesis of COPD (Grigg, 
2009). First, attenuation of lung growth due to air pollution in childhood is a risk factor for 
adult-onset respiratory disease. Second, there may be common cellular and molecular 
mechanisms underlying impaired pulmonary innate host defenses in children exposed to air 
pollution, and susceptibility to infection in COPD. Third, lung damage initiated in 
childhood may contribute to an emerging global health issue, namely, COPD due to smoke 
exposure. 
Studies showing an association between lifelong organic smoke and the development of 
COPD in nonsmoking women provides a direct link between exposure of children to PM 
and increased vulnerability to respiratory disease in adulthood (Grigg, 2009). Chronic 
exposure to PM (Grigg, 2009) likely interferes with maximal lung function attainment in 
childhood, accelerates lung function decline in adulthood, stimulates airway mucus 
production, and impairs pulmonary innate immunity. Similar associations between air 
particulate pollution (PM10 or PM2.5) and hospital admissions for COPD have been 
reported for a variety of urban areas (Yang et al., 2005). The strong association between 
respiratory hospital admissions and PM10 pollution (Pope, 1991) supports the role of PM10 
in the incidence and severity of respiratory disease. 
Long-term studies usually use a cohort design when comparing mortality across 
populations, and vary in their long-term exposure to air pollution. An overall reduction in 
PM 2.5 levels over time results in reduced long-term risk of death due to cardiovascular 
and/or respiratory disease (Laden et al., 2006). A large European cohort study of mortality 
and air pollution showed smaller effective estimates, which were significant only for all-
cause and respiratory mortality (Beelen et al., 2008). Epidemiological studies from controlled 
human exposure to toxins have identified characteristics of populations that may be more 
susceptible to PM-related health issues (Sacks et al., 2011): children and older adults with 
preexisting cardiovascular and respiratory diseases, populations with lower income and less 
education, and the presence of genetic polymorphisms. In addition, PM-related health 
effects are sometimes observed in individuals with diabetes, COPD, and increased body 
mass index. A cohort study of Swiss adults demonstrated that a decrease in ambient PM10 
was associated with reduced respiratory symptoms (Schindler et al., 2009). 
Given the increasing evidence that air pollution has both short- and long-term effects on 
health, the public health impact of reducing pollutant levels has gained attention. A large 
study across 211 U.S. counties demonstrated significant improvements in life expectancy 
related to reductions in PM2.5 concentrations (Pope et al., 2009).  
3. Molecular mechanisms in in vitro and in vivo studies (Figure 2) 
Because the lung interfaces with the external environment and is frequently exposed to air 
pollutants, such as PM, it is prone to oxidant-mediated cellular damage (Nel et al., 2006). 
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The adverse health effects of particulate pollutants may be explained by several 
mechanisms, including innate immunity, adaptive immunity, and the production of reactive 
oxygen species (Nel et al., 2006). 
 
Figure 2. Proposed mechanism of lung diseases by PM. 
Innate immunity 
The pathways associated with acute inflammation in response to particle exposure involve 
an orchestrated sequence of events, mediated in part by chemokines and cytokines 
(Seagrave, 2008). Particles larger than 10 m generally get caught in the nose and throat, and 
never enter the lungs (Yang & Omaye, 2009). After inhalation of PM, phagocytic cells 
including neutrophils and macrophages are recruited to the foreign particle by cytokines 
and chemokines, and transported by the mucociliary escalator for removal (Donaldson and 
Tran, 2002). PM induces the release of inflammatory cytokines, such as IL-6, IL-8, GM-CSF, 
and TNF-(Stone et al., 2007) from immune cells (e.g., macrophages) as well as structural 
airway cells (Totlandsdal et al., 2010). 
DEPs exert their effect through agents such as polyaromatic hydrocarbons (PAHs). The 
particles are deposited on the airway mucosa; their hydrophobic nature allows them to 
diffuse easily through cell membranes and to bind to cytosolic receptor complexes. Through 
subsequent nuclear activity, PAHs can modify both cell growth and cell differentiation 
programs. 
Experimental studies have shown that DEP-PAHs can modify the immune response in 
animals and humans and modulate airway inflammatory processes. In other words, DEPs 
exert an adjuvant immunological effect on IgE synthesis in atopic subjects, thereby causing 
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sensitization to airborne allergens (Diaz Sanchez et al., 1997). They also cause respiratory 
symptoms and modify the immune response in atopic subjects (Rield & Diaz-Sanchez, 2005, 
Diaz Sanchez et al., 1997), and can interact with aeroallergens to enhance antigen-induced 
responses, with the result that allergen-specific IgE levels are up to 50-fold greater in allergic 
patients stimulated with DEPs and allergens than in patients treated with allergen alone 
(Diaz Sanchez et al., 1997). A combined challenge of DEPs and ragweed allergen markedly 
increases the expression of human nasal ragweed-specific IgE in vivo and skews cytokine 
production to a type 2 helper T-cell pattern (Diaz Sanchez et al., 1997).  
Chitin is commonly found in organisms including parasites, fungi, and bacteria, but does 
not occur in mammalian tissues (Guo et al., 2000), allowing for selective antimicrobial 
activity of chitinase. Macrophage-synthesized Ym1 and Ym2 are homologous to chitinase, 
and have chitinase activity (Sun et al., 2001, Jin et al., 1998). Through the IL-4/STAT 6 signal 
transduction pathway, Ym1 was implicated in allergic peritonitis (Welch et al., 2002). Acid 
mammalian chitinase may also be an important mediator of IL13-induced responses in Th2 
disorders, such as asthma (Zhu et al., 2004). Indeed, polymorphisms in acid mammalian 
chitinase are associated with asthma, further supporting the involvement of acid 
mammalian chitinase in asthma development (Bierbaum et al., 2005). DEP induces airway 
hyper-responsiveness as well as Ym mRNA expression, a Th2 cell-biased response by 
activated macrophages. The chitinase Ym1 is expressed in the spleen and lungs, with lower 
expression in the thymus, intestine, and kidney, whereas Ym2 is expressed at high levels in 
the stomach, with lower levels in the thymus and kidney (Ward et al., 2001). Conserved 
STAT6 sites probably account for the similar, striking induction of Ym1 and Ym2 expression 
in Th2-type environments. In a murine model of DEP exposure, with BALB/c mice exposed 
intranasally to DEP followed by a DEP challenge, upregulation of lung-specific expression 
of Ym1 and Ym2 transcripts was seen relative to mice that were not exposed nor similarly 
challenged (Song et al., 2008). Alveolar macrophages play an important role in particle-
induced airway and lung inflammation via direct production of IL-13. Treatment of 
epithelial cells with bovine serum albumin-coated titanium dioxide particles led to 20 
altered proteins on two-dimensional gels, which were further analyzed by nano-LC-MS/MS. 
These proteins included defense-related, cell-activating, and cytoskeletal proteins implicated 
in responses to oxidative stress (Kang et al., 2005). Titanum dioxide (TiO2) treatment 
increased macrophage migration-inhibitory factor (MIF) mRNA levels. MIF was expressed 
primarily in the epithelium and was elevated in lung tissues and bronchoalveolar lavage 
(BAL) fluids of TiO2-treated rats, compared to sham-treated rats. Carbon and DEPs also 
induce the expression of MIF protein in epithelial cells. The regulation and function of 
chitinase has not been well explored in air pollution asthma models. However, in one study, 
Ym1 was one of the most highly induced IL-4 target genes, exhibiting at least a 70-fold 
increase in macrophage populations (Kang et al., 2005). Nitric oxide (NO) was shown to be a 
short-lived molecule that causes vasodilation and bronchodilation (Moncada et al., 1991). In 
that study, the nitrite concentration in BAL fluids, indicative of the in vivo generation of NO 
in the airways, was significantly greater in DEP-exposed animals than in the control group. 
In another study, alveolar macrophages produced nitrite during in vitro exposure to DEP 
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particles (50 g/ml), with maximal induction 4 h after exposure (Song et al., 2008). The 
inflammatory effects of PM 10 were demonstrated in experimental animal studies following 
direct instillation into the lung, prior to human studies that showed the pulmonary effects 
after experimental exposure to PM (Ghio & Devlin, 2001). Clinically, PM 10 particles likely 
provoke airway inflammation via the release of mediators that exacerbate lung disease in 
susceptible individuals (Seaton et al., 1995); even a single exposure compromises a host’s 
ability to handle ongoing pulmonary infections (Zelikoff et al., 2003). Fine and ultra-fine 
particles directly stimulate macrophages and epithelial cells to produce inflammatory 
cytokines such as TNF-, TGF-1, GM-CSF, PDGF, IL-6, and IL-8 (Fugii et al., 2001), and 
reactive oxygen species are responsible for acute and chronic lung inflammation (Li et al., 
2003).  
Adaptive immunity 
PM induces a Th2-like environment, with the overproduction of IL-4 and IL-13 (Kang et al., 
2005). We found that IL-13 mRNA levels in lung tissue extracts were significantly increased 
24 h after treatment with TiO2 particles, compared to sham-treated rats (Kang et al., 2005). 
IL-13 levels were also significantly increased in the BAL fluids of TiO2-treated rats 72 h after 
treatment (n=8), relative to sham-treated rats (n=8). To investigate the time- and dose-
dependency of macrophage IL-13 production, purified alveolar macrophages were 
stimulated with 1, 10, and 40 g/ml TiO2 for 24, 48, and 72 h (n=6 in each experiment). The 
control group (n=6) consisted of untreated alveolar macrophages. IL-13 levels in the 
supernatants of the macrophage cultures were measured by ELISA. Macrophages that were 
cultured for 48 h with TiO2 produced IL-13 in a dose-dependent manner. In addition, 10 
g/ml TiO2 significantly enhanced IL-13 production relative to controls. IL-13 protein 
production increased in a time-dependent manner, and peaked 48 h after TiO2 exposure. 
Using immunohistochemical staining, we also found that TiO2-engulfing macrophages were 
the main source of IL-13 in TiO2-particle-induced lung inflammation. Taken together, our 
results suggest that alveolar macrophages may be major effectors of innate immunity by 
modulating inflammatory responses towards a Th2-phenotype by producing IL-13, as seen 
in the adaptive immune response (Figure 3). Proteomics offers a unique means of analyzing 
expressed proteins, and was successfully used to examine the effects of oxidative stress at 
the cellular level. In addition to revealing protein modifications, this approach can also be 
used to look at changes in protein expression levels (Blackford et al., 1997). In a previous 
study, 20 proteins were identified (Table 1) whose expression levels in the human bronchial 
epithelial cell line BEAS-2B changed in response to TiO2 particle exposure (Cha et al., 2007). 
These proteins included defense-related, cell-activating, and cytoskeletal proteins implicated 
in the response to oxidative stress, and can be classified into four groups according to the 
pattern of their TiO2-induced change in expression over time (Figure 4). One protein, MIF, 
was induced at the transcriptional level by stimulation of cells with any of three different 
particulate molecules; expression of MIF increased in lungs of TiO2-instilled rats. These 
results indicate that some of these proteins may serve as mediators of, or markers for, 
airway disease caused by exposure to PM. 
 




Figure 3. Time and dose responses of IL-13 production by macrophages exposed to TiO2 particles. 
Purified alveolar macrophages stimulated with 1, 10, and 40 g/ml TiO2 for 24, 48, and 72 h (n=6 in each 
experiment). The control group (n=6) consisted of unstimulated alveolar macrophages. The IL-13 in the 
48-h culture supernatants is produced in a dosedependent manner after TiO2 treatment (A). TiO2 
concentrations  10 g/ml significantly enhance IL-13 production when compared with the control group. 
The production of IL-13 protein is increased in a time-dependent manner and peaks 48 h after TiO2 
stimulation (B). The results are expressed as means ± SEM. * Significant difference (P< 0.05) when 
compared with the control group. 
 
 
Table 1. List of proteins identified by LC-MS/MS analysis  
 




Figure 4. Cluster analysis of 20 proteins with significant differential expression (>2-fold change) at 8 or 
48 h caused by TiO2 treatment of BEAS-2B epithelial cells. The expression profiles of the individual 
proteins were classified by cluster analysis. Protein names (National Center for Biotechnology 
Information (NCBI)) are displayed for each cluster.  
However, there is a lack of evidence showing a direct relationship between particulates and 
the induction of Th2-like cytokines, including IL-4 and IL-13. TiO2 particles are a 
component of PM 10 found in dusty workplaces in industries involved in the crushing and 
grinding of the mineral ore rutile (Templeton, 1994). Garabrant et al. (1987) reported that 
50% of TiO2-exposed workers have respiratory symptoms accompanied by reduced 
pulmonary function. Because acute and chronic exposures to TiO2 particles also induce 
inflammatory responses in the airways and alveolar spaces of rats (Ahn et al., 2005, Kang et 
al., 2005, Schapira et al., 1995, Waheit et al., 1997), TiO2-treated rats are good models for 
studying epithelial responses to PM10 particles. Proteomics has been successfully used to 
examine oxidative stress at the cellular level (Xiao et al., 2003). PM10 or DEP increase lung 
inflammation by inhalant allergens or respiratory viral infection by acting as adjuvants. The 
response may enhance already existing allergies or IgE responses to neo-allergens and 
susceptibility to respiratory infection. This adjuvant effect is exerted by the enhanced 
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production of inflammatory Th2 and/or Th1 cytokines (Diaz-Sanchez et al., 1997). In animal 
experiments and human studies, several cytokines and CC chemokines including IL-4, IL-5, 
IL-13, GM-CSF, RANTES, MCP-3, MIP-1 were increased when lymphocytes and 
macrophages/monocytes were co-stimulated with particulates in the presence of specific 
allergens (Hamilton et al., 2004). The immune system responds in different ways depending 
on the type of particulate. DEP favors a Th2 response, while asbestos fiber and carbon 
particles upregulate both Th1 and Th2 cytokines produced by autologous lymphocyte 
stimulated by antigen (Hamilton et al., 2004). In addition to the adjuvant effects, inhaled 
inert particles cause a spectrum of pulmonary responses, ranging from minimal changes to 
marked acute and chronic inflammation. 
Oxidative stress 
ROS production and the generation of oxidative stress are relevant to lung diseases. Oxygen 
is readily reduced with an electron to form oxygen free radicals, such as superoxide (Bast, et 
al., 2010, Finkel, 2011, Comhair & Erzyrum, 2010). Superoxide takes up a second electron, 
leading to hydrogen peroxide, which will generate the extremely reactive hydroxyl radical 
in the presence of iron ions. Hydroxyl radicals react very quickly with biomolecules, such as 
proteins, fatty acids, and DNA (Bast, et al., 2010, Finkel, 2011, Comhair & Erzyrum, 2010). 
All molecules in the direct vicinity of the hydroxyl radical will react with this reactive form 
of oxygen (Bast, et al., 2010, Finkel, 2011, Comhair & Erzyrum, 2010). The various forms of 
oxygen are called ROS (Bast, et al., 2010). Formation of ROS takes place constantly in every 
cell during normal metabolic processes (Bast, et al., 2010, Finkel, 2011, Ballaban, et al., 2005, 
Comhair & Erzyrum, 2010). Cellular sites for production of ROS include mitochondria,  
microsomes, and enzymes (e.g., xanthine oxidase, P450 monooxygenase, cyclooxygenase, 
lipoxygenase, indole amine dioxygenase, monoamine oxidase) (Nadeem, et al., 2008). One of 
the most dangerous forms of PM pollution is diesel exhaust particles. Diesel exhaust 
particles consist of polyaromatic hydrocarbons, hydrophobic molecules that can diffuse 
easily through cell membranes. As free radicals cause oxidative damage to biological 
macromolecules, such as DNA, lipids, and protein, they are believed to be involved in the 
pathogenesis of many diseases (Tredaniel, et al., 1994). The particles are able to induce the 
generation of free radicals, which may lead to an increase in oxidative stress, exacerbating 
some respiratory symptoms. Metals present on the particle surface, including Fe, Co, Cr, 
and V, undergo redox cycling, while Cd, Hg, and Ni, as well as Pb, deplete glutathione and 
protein-bound sulfhydryl groups resulting in ROS production (Stohs, et al., 2001, Valko, et 
al., 2005). Metal-induced oxidative stress has been shown to subsequently affect the immune 
system, by causing neutrophilic lung injury and release of inflammatory mediators by 
several lung cell types (Ghio & Delvin, 2001), and to act as the cornerstone for subsequent 
particle-induced inflammation (Dye et al., 1999). Another mechanism involves phagocytosis, 
characterized by the removal of microorganisms and pollutant particles (Forman & Toress, 
2001), and an essential element of the immune defense system, which may mediate alveolar 
macrophage binding of certain inert and environmental particulate matter, such as Fe2O3, 
silicates, TiO2, quartz, and iron oxide (Cha et al., 2007). Redox reactions regulate signal 
transduction as important chemical processes. The response of a cell to a reactive oxygen-
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rich environment often involves the activation of numerous intracellular signaling 
pathways, which can cause transcriptional changes and allow the cells to respond 
appropriately to the perceived oxidative stress (Finkel, 2011, Comhair & Erzyrum, 2010). 
Nuclear factor-κB (NF-κB) and activation protein-1 (AP-1) are regulated and influenced by 
the redox status and have been implicated in the transcriptional regulation of a wide range 
of genes involved in oxidant stress and cellular response mechanisms (Beamer & Holian, 
2005). In the nucleus, redox affects histone acetylation and deacetylation status, which at 
least partly regulates inflammatory gene expression by activation of redox-sensitive 
transcription factors (Liu, et al., 2005). NF-κB is activated in epithelial cells and 
inflammatory cells during oxidative stress, leading to the upregulation of a number of 
proinflammatory genes (Beamer & Holian, 2005). NF-κB is a protein heterodimer made up 
of p65 and p50 subunits. There is evidence of activation of NF-κB in bronchial mucosa and 
sputum inflammatory cells in asthmatic patients (Rhaman, et al., 1996). Many of the 
inflammatory genes responsible for the pathogenesis of asthma are regulated by NF-kB. AP-
1 is a protein dimer composed of a heterodimer of Fos and Jun proteins. AP-1 regulates 
many of the inflammatory and immune genes in oxidant-mediated diseases. Gene 
expression of gamma-glutamylcysteine synthetase, the rate-limiting enzyme for GSH 
synthesis, is induced by the activation of AP-1. In addition, the family of mitogen-activated 
protein kinases (MAPKs) is directly or indirectly altered by redox changes (Ciencewicki, et 
al., 2008). Oxidative stress and other stimuli, such as cytokines, activate various signal 
transduction pathways leading to activation of transcription factors, such as NF-kB and AP-
1 (Rahman & Adcock, 2006). Binding of transcription factors to DNA elements leads to 
recruitment of CREB-binding protein (CBP) and/or other co-activators to the transcriptional 
initiation complex on the promoter regions of various genes (Rahman & Adcock, 2006). 
Activation of CBP leads to acetylation of specific core histone lysine residues by an intrinsic 
histone acetyltransferase activity (Rahman & Adcock, 2006). Redox changes also can activate 
members of the MAPK, such as extracellular signal-regulated kinase, c-jun N-terminal 
kinase, p38 kinase, and phosphoinositol-3 kinase, all of which may ultimately promote 
inflammation (Carvalho, et al., 2004). Both STAT1 and STAT3 activation are regulated by 
redox (Carvalho, et al., 2004). NF-E2-related factor 2, a basic leucine zipper transcription 
factor, involved in induction of the antioxidant element (ARE)-mediated transcriptional 
response is known to play an important role and binds to the ARE and upregulates the 
expression of several antioxidant genes in response to a variety of stimuli (Nguyen, et al., 
2003). ROS (Nadeem, et al., 2008) can influence airway cells and reproduce many of the 
pathophysiological features associated with asthma by initiating lipid peroxidation, altering 
protein structure, enhancing release of arachidonic acid from cell membranes, contracting 
airway smooth muscle, increasing airway reactivity and airway secretions, increasing 
vascular permeability, increasing the synthesis and release of chemoattractants, inducing the 
release of tachykinins and neurokinins, decreasing cholinesterase and neutral 
endopeptidase activities, and impairing the responsiveness of ß-adrenergic receptors 
(Barnes, et al., 1998). Asthma attacks and experimental allergen challenge are associated 
with immediate formation of superoxide that persists throughout the late asthmatic 
response (Calhoun, et al., 1992). Allergen challenge in the airways of atopic individuals 
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caused a twofold increase in superoxide generation (Calhoun, et al., 1992). Spontaneous and 
experimental allergen-induced asthma attacks lead to eosinophil and neutrophil activation, 
during which NADPH oxidase is activated and ROS such as superoxide and its dismutation 
product H2O2 are rapidly formed (Klebanoff, 1980). ROS production by asthmatics correlates 
with the severity of airway reactivity (Calhoun, et al., 1992). Asthma is characterized by 
oxidative modifications (Sansers, et al., 1995). Increased levels of EPO and MPO parallel the 
numbers of eosinophils and neutrophils, respectively, and are found at higher than normal 
levels in asthmatic peripheral blood, induced sputum, and BAL fluid (Sansers, et al., 1995). 
Malondialdehyde and thiobarbituric acid-reactive substances have also been detected in 
urine, plasma, sputum, and BAL fluid in relation to the severity of asthma (Mondino, et al., 
2004, Wood, et al., 2005) In addition, 8-isoprostane, a biomarker of lipid peroxidation, is also 
elevated in exhaled breath condensate from adults and children with asthma (Mondino, et 
al., 2004, Wood et al, 2005). Generation of reactive oxygen and nitrogen species is markedly 
increased during acute asthma attacks (MacPherson, et al., 2001, Wu, et al., 2000). The loss of 
SOD contributes to oxidative stress during acute episodes of asthma exacerbation 
(MacPherson et al, 2001, Wu et al, 2000). Oxidative modification of MnSOD is present in 
asthmatic airway epithelial cells (Malik & Storey, 2011).The loss of SOD activity reflects the 
increased oxidative and nitrative stress in asthmatic patients, suggesting that SOD may 
serve as a surrogate marker of oxidant stress and asthma severity (Takaku, et al., 2011). ROS, 
such as superoxide and hydrogen peroxide, enhance vascular endothelial growth factor 
(VEGF) expression (Kuroki, et al., 1996), while exogenous SOD prevents VEGF expression 
(Kuroki, et al., 1996), suggesting that the increased vascularization found in asthma may be 
due to the involvement of oxidative stress via effects on hypoxia-inducible factors (Ghosh, et 
al., 2003). The catalase activity was found to be 50% lower in BAL fluid of asthmatic lungs 
than that in healthy controls (Ghosh, et al., 2003). Tyrosine oxidant modifications of catalase 
occur in asthma, such as chlorination of tyrosine by peroxidase-catalyzed halogenation, and 
oxidative cross-linking of tyrosine as monitored by dityrosine, a product of tyrosyl radicals 
(Ghosh, et al., 2003). The most extensive modification found in asthmatic lungs is tyrosine 
chlorination, which is 20-fold more extensive than tyrosine nitration (Ghosh, et al., 2003). In 
contrast to SODs and catalase, extracellular GPx is present at higher than normal levels in 
the lungs of individuals with asthma (Comhair, et al., 2002). This increase is due to 
induction of GPx mRNA and protein expression by bronchial epithelial cells in response to 
increased intracellular or extracellular ROS [94]. During asthma exacerbation in humans, the 
levels of serum TRX1 increase and are inversely correlated with airflow (Yamada, et al., 
2003). Cigarette smoke can induce increased oxidant burden and cause irreversible changes 
to the antioxidant protective effects in the airways (van Der Troorn, et al., 2007). The smoke-
derived oxidants damage airway epithelial cells inducing direct injury to membrane lipids, 
proteins, carbohydrates, and DNA, leading to chronic inflammation (Foronjy, et al., 2008). 
Cigarette smoking delivers and generates oxidative stress within the lungs (Lin & Thoma, 
2010) These imbalances of oxidant burden and antioxidant capacity have been implicated as 
important contributing factors in the pathogenesis of COPD (Lin & Thoma, 2010) However, 
smoking also causes the depletion of antioxidants, which further contributes to oxidative 
tissue damage (Lin & Thoma, 2010) The downregulation of antioxidant pathways has also 
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been associated with acute exacerbations of COPD (Lin & Thoma, 2010). Disruption of the 
oxidant/antioxidant balance is important in the pathogenesis of acute lung injury and acute 
respiratory distress syndrome. Different cytokines and growth factors play a role in the 
pathogenesis of lung fibrosis (Hecker, et al., 2009). ROS mediate the formation of TGF-β in 
lung epithelial cells (Hecker, et al., 2009). Fibroblasts of patients with idiopathic pulmonary 
fibrosis produce H2O2 upon stimulation with TGF-β. This interplay between H2O2 and TGF-
β leads to deterioration of re-epithelialization and fibrosis (Hecker, et al., 2009).  
4. Conclusions 
Epidemiological surveys and animal studies together suggest that air pollutants are 
involved in the pathogenesis of airway inflammation and aggravate respiratory symptoms. 
Avoidance of harmful exposures is a key component of national and international guideline 
recommendations for the management of respiratory diseases. Controlling air pollution is 
important for the prevention of airway diseases. Finally, in vitro and in vivo studies are 
needed to further delineate the role of particulate air pollutants in airway diseases and the 
molecular mechanisms involved. 
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